We thank Drs Huisingh and McGwin for their interest in our paper and their general comments on our statistical analysis. Because our study participants were selected based on their disease status, case-control study may more appropriately describe ou…
Ranibizumab in Myopic Choroidal Neovascularization: The 12-Month Results from the REPAIR Study
The REPAIR study was a phase II, prospective, multicenter, industry-sponsored study (clinical trial registration: http://clinicaltrials.gov/; identifier: NCT01037348) of intravitreal ranibizumab in myopic choroidal neovascularization (CNV). The purpose…
Author reply
We would like to thank Galvis et al for their comments on our article. It has been demonstrated by us that the sensitivity of potassium hydroxide (KOH) in detecting fungal elements was 94.3%. This has also been substantiated by other authors who repor…
Author reply
We thank Matonti et al for their interest in our study (SECURE). Matonti et al mention in their letter that the mean BCVA decrease of 4.3 letters from baseline observed in the SECURE study may be owing to retinal nerve fiber layer (RNFL) decrease and…
Cyclosporine A Drug-Delivery System for High-risk Keratoplasty
We read the article by Shi et al reporting the efficacy of a novel cyclosporine (CsA) drug delivery system (DDS) for suppressing the occurrence of rejection and improving the survival of corneal allografts after high-risk keratoplasty with great inter…
Fluoroquinolones in Corneal Ulcers
We read with interest the article by Sharma et al on moxifloxacin 0.5% in treatment of corneal ulcers. Authors indicated that corneal scrapings were examined using the Gram stain and potassium hydroxide wet mount, and that any case showing fungal elem…